Novavax Inc banner

Novavax Inc
F:NVV1

Watchlist Manager
Novavax Inc Logo
Novavax Inc
F:NVV1
Watchlist
Price: 7.94 EUR -2.1%
Market Cap: €1.2B

Wall St Price Targets

NVV1 Price Targets Summary
Novavax Inc

Wall Street analysts forecast NVV1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVV1 is 10.91 EUR with a low forecast of 5.36 EUR and a high forecast of 19.9 EUR.

Lowest Forecast
Price Target
5.36 EUR
32% Downside
Average Forecast
Price Target
10.91 EUR
37% Upside
Highest Forecast
Price Target
19.9 EUR
151% Upside
Novavax Inc Competitors:
Price Targets
PGEN
Precigen Inc
136% Upside
DXPE
DXP Enterprises Inc
-14% Downside
CDNA
CareDx Inc
-3% Downside
QXO
SilverSun Technologies Inc
88% Upside

Revenue
Forecast

35% / Year
Past Growth
-32% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
35% / Year
Past Growth
-32% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is -32%.

Gross Profit
Forecast

46% / Year
Past Growth
-31% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
46% / Year
Past Growth
-31% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 46%. The projected CAGR for the next 3 years is -31%.

Operating Income
Forecast

N/A
Past Growth
-47% / Year
Estimated Growth
Estimates Accuracy
28%
Average Beat
N/A
Past Growth
-47% / Year
Estimated Growth
Estimates Accuracy
28%
Average Beat

The compound annual growth rate for Operating Income over the next 3 years is -47%.

Pre-Tax Income
Forecast

N/A
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

The compound annual growth rate for Pre-Tax Income over the next 3 years is -41%.

Net Income
Forecast

N/A
Past Growth
-44% / Year
Estimated Growth
Estimates Accuracy
21%
Average Beat
N/A
Past Growth
-44% / Year
Estimated Growth
Estimates Accuracy
21%
Average Beat

The compound annual growth rate for Net Income over the next 3 years is -44%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NVV1's stock price target?
Price Target
10.91 EUR

According to Wall Street analysts, the average 1-year price target for NVV1 is 10.91 EUR with a low forecast of 5.36 EUR and a high forecast of 19.9 EUR.

What is the Revenue forecast for Novavax Inc?
Projected CAGR
-32%

Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is -32%.

What is the Gross Profit forecast for Novavax Inc?
Projected CAGR
-31%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 46%. The projected CAGR for the next 3 years is -31%.

What is the Operating Income forecast for Novavax Inc?
Projected CAGR
-47%

The compound annual growth rate for Operating Income over the next 3 years is -47%.

What is the Pre-Tax Income forecast for Novavax Inc?
Projected CAGR
-41%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -41%.

What is the Net Income forecast for Novavax Inc?
Projected CAGR
-44%

The compound annual growth rate for Net Income over the next 3 years is -44%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett